Price:
Rs. 5,250.00
Sample Type: Amniotic fluid , EDTA Blood
Fasting Not Required
Notes:Q8101
Frequently Asked Questions (FAQ's):
What does this QF-PCR test detect?
It identifies chromosomal aneuploidies involving chromosomes 13, 18, 21, and XY to screen for major fetal genetic disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses Quantitative Fluorescent PCR (QF-PCR) to analyze STR markers for rapid and precise detection.
Who should consider taking this test?
Expectant mothers undergoing prenatal screening, those with abnormal ultrasound findings, or those advised by a clinician.
What sample is required for this test?
It typically analyzes fetal DNA obtained through invasive procedures like amniocentesis or chorionic villus sampling (CVS).
How quickly are QF-PCR results available at Metropolis Healthcare?
Results are usually available within a short turnaround time due to the rapid nature of QF-PCR technology.
Does this test replace a full karyotype?
It provides rapid screening for common aneuploidies but may be complemented by additional genetic tests if needed.
Is fasting required before the procedure?
No fasting is required; however, the sample collection method depends on the clinician’s recommendation.
Can this test determine fetal gender?
Yes, by analyzing X and Y chromosome markers, QF-PCR can determine fetal sex as part of the assessment.